Skip to Main Content

Paper Details

An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer.
Nat Cell Biol
66
2021
AR, AR cistrome, Cancers, EZH2, androgen, androgen receptor, chromatin, enhancer of zeste homologue 2, epithelial lineage, polycomb subcomplex, prostate cancer, reprogrammed, stem cell and neuronal gene networks, treatment, tumours
Author NameAffiliation
Alastair DaviesUniversity of British Columbia
Alastair Davies
Andries M BergmanThe Netherlands Cancer Institute, Oncode Institute
Musaddeque AhmedPrincess Margaret Cancer Center, University Health Network
Musaddeque AhmedUniversity of Toronto
Ladan Fazli
Felix Y FengUniversity of California San Francisco
Martin E GleaveUniversity of British Columbia
Martin E Gleave
Housheng Hansen HePrincess Margaret Cancer Center, University Health Network
Housheng Hansen HeUniversity of Toronto
Faraz Hach
Faraz HachSimon Fraser University
Wilbert ZwartThe Netherlands Cancer Institute, Oncode Institute
Himisha BeltranDana Farber Cancer Institute, Harvard Medical School
Himisha BeltranDana Farber Cancer Institute, Harvard Medical School
Luke A SelthAdelaide Medical School, University of Adelaide
Luke A SelthAdelaide Medical School, University of Adelaide
Luke A SelthFlinders Health and Medical Research Institute, Flinders University, College of Medicine and Public Health
Amina ZoubeidiUniversity of British Columbia
Amina Zoubeidi
  • 1 - 21

Datasets